ABOS · Acumen Pharmaceuticals, Inc. · Investor Relations
$0.19
-0.01 (-3.52%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Oct 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current operating plan, we believe there is substantial doubt about our ability to continue as a going concern for at least 12 months following the date of issuance of our unaudited condensed financial statements included in this Quarterly Report on Form 10-Q.”View the 10-Q filed Oct 26, 2026
Market Cap
$13.49M
Shares
72.33M
Volume · Nov 20
2.71M
Avg daily vol (3M)
2.7M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
Key facts
CIK
1576885
CUSIP
00509G209
13F (30d)
103 filings
89 filers
Visit website
Investor relations